Pharmacotherapy of COVID-19

Corona virus disease is a pandemic that first reported from Wuhan City of China and later spread to other parts of the world. It is a highly contagious disease though the mortality rate is less compared to other corona virus disease seen in the last two decades. Most of the infected individuals are asymptomatic and goes unnoticed. However, 5-10 percent requires hospitalization and 1-3 percent may need critical care management. There is no proven drug for the disease, but many existing drugs are repurposed for this disease with variable degree of success. Few clinical trials are completed and some are still undergoing. An attempt is made to give an overview of various drugs available at present for the management of COVID-19 and in various stages of their development.